Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue-based combination therapy for Plasmodium vivax malaria
NCT02696928Phase 2Withdrawn
- Sponsor
- Heidelberg University
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of methylene blue in vivax malaria, sponsored by Heidelberg University. Planned start Apr 2016; status: withdrawn.
02
Drugs
methylene blue
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT02696928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696928.